论文信息 - Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma. - 字舞流文

Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.

W. Miller | N. Ibrahim | C. Robert | C. Lebbé | E. Richtig | Wei Zhou | J. Cebon | M. Middleton | N. Steven | G. Masucci | E. Walpole | T. Petrella | D. Hille